RAPID ACCELERATION OF DIAGNOSTICS TECHNOLOGY (RADx® Tech) FOR MATERNAL HEALTH CHALLENGE

快速加速诊断技术（RADx® Tech）的孕产妇健康挑战赛将提供高达800万美元的奖金，以加速开发基于家庭和护理点（POC）的孕产妇健康诊断设备，可穿戴设备或其他遥感技术。成功的技术将能够扩大护理范围（例如，为个人提供可操作的健康信息，使他们能够决定何时寻求额外的护理），并最终降低产后第一年（从分娩之日或妊娠结束）居住在产妇护理沙漠中的个人的严重产妇发病率和产妇死亡率（SMM/MM）。参与这项挑战的创新者将提交一份提案，详细描述他们的原型技术，预期的临床影响和持续发展计划。这些提案将在可行性评估阶段进行审查，从中选出的获奖者将进入深潜评估阶段。在深入研究阶段，由医疗技术商业化和内容专家组成的项目团队将直接与每个创新者合作，根据定义的评估标准评估原型技术，并与NIH合作，确定加速开发和实施的关键风险因素，并建立减轻这些风险的里程碑，最终由NIH决定。在深潜阶段选出的创新者将获得现金奖励，并进入技术评估阶段，在此阶段，他们将通过实物技术，临床和商业化支持迅速降低其技术的风险，并为成功完成里程碑而竞争额外的现金奖励。在技术评估阶段结束时，创新者将提交他们的技术进行独立的性能和可用性测试和验证。那些技术成功完成最后阶段的创新者将获得现金奖励，并与NIH资助的研究网络和中心建立联系，以探索自己的合作。鼓励获奖者申请额外的NIH资金，以继续开发他们的技术，但这种资金是不能保证的，并受到相关资助机会公告的标准竞争和申请要求的约束。RADx技术的孕产妇健康挑战是美国国立卫生研究院实施孕产妇健康和Pregnancy成果愿景为每个人（改善）倡议的一部分，该倡议支持研究重点是减少孕产妇死亡的可预防原因，改善妇女在分娩前，分娩期间和分娩后的健康状况。

The Rapid Acceleration of Diagnostics Technology (RADx® Tech) for Maternal Health Challenge will award up to $8 million in prizes to accelerate the development of home-based and point-of-care (POC) maternal health diagnostic devices, wearables, or other remote sensing technologies. Successful technologies will enable extension of care (e.g., empower individuals with actionable health information they can use to inform their decisions about when to seek additional care) and ultimately reduce severe maternal morbidity and maternal mortality (SMM/MM) for individuals residing in maternity care deserts during the first year of the postpartum period (from day of delivery or end of pregnancy). Innovators participating in this challenge will submit a proposal describing in detail their prototype technology, anticipated clinical impact, and plans for continued development. These proposals will be reviewed during the Viability Assessment Phase from which selected winners will advance to the Deep Dive Assessment Phase. During the Deep Dive Phase, a Project Team of healthcare technology commercialization and content experts will engage directly with each Innovator to assess the prototype technology across defined Evaluation Criteria and will work with NIH to identify key risk factors for accelerated development and implementation and establish milestones that mitigate these risks, subject to final decisions by NIH. Innovators selected in the Deep Dive Phase will receive a cash prize and advance to the Technology Assessment Phase where they will rapidly de-risk their technologies with in-kind technical, clinical, and commercialization support and compete for an additional cash prize for successful milestone completion. At the end of the Technology Assessment Phase, Innovators will submit their technologies for independent testing and verification of performance and usability. Those Innovators whose technologies successfully complete the final phase will be rewarded with a cash prize and connected to NIH-funded research networks and centers to explore collaborations on their own. Winners are encouraged to apply for additional NIH funding to continue development of their technologies, but such funding is not guaranteed and is subject to the standard competition and application requirements of the relevant funding opportunity announcements. The RADx Tech for Maternal Health Challenge is part of the NIH Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE) Initiative which supports research focused on reducing preventable causes of maternal deaths and improving health for women before, during, and after delivery.